Dallas, Texas--(Newsfile Corp. - October 30, 2020) - PAO Group, Inc. (OTC Pink: PAOG) and Puration, Inc. (OTC: Pink: PURA) today released an update on the process underway for PAOG to issue PAOG ...
DALLAS, Oct. 30, 2020 /PRNewswire/ -- PAO Group, Inc. (USOTC: PAOG) and Puration, Inc. (USOTC: PURA) today released an update on the process underway for PAOG to issue PAOG shares to PURA shareholders ...
Sandusky, OH, Oct. 13, 2021 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today announced encountering a flurry of outside interest of late into the company’s CBD pharmaceutical respiratory ...
SANDUSKY, Ohio, April 13, 2021 /PRNewswire/ — PAO Group, Inc. (USOTC: PAOG) today released a management update on the company’s ongoing CBD Pharmaceutical Development Program. Last year, PAOG acquired ...
SANDUSKY, Ohio, May 13, 2021 /PRNewswire/ — PAO Group, Inc. (USOTC: PAOG) today revealed it will include foreign sales in the planned Q4 launch of its three CBD Nutraceutical Products. The 2020 CBD ...
PAOG Announces CEO Interview Discussing Cannabis Investigational New Drug Application Plans With FDA
SANDUSKY, Ohio, Oct. 2, 2020 /PRNewswire/ -- PAO Group, Inc. (USOTC: PAOG) today announced an interview of CEO Jim DiPrima on MoneyTV where Mr. DiPrima discusses recent news regarding PAOG's latest ...
SANDUSKY, Ohio, Oct. 1, 2020 /PRNewswire/ -- PAO Group, Inc. (USOTC: PAOG) today announced engaging Saul Kaye the founder of iCAN (www.israel-cannabis.com) and CannaTech (www.canna-tech.co) to provide ...
SANDUSKY, Ohio, April 8, 2021 /PRNewswire/ — PAO Group, Inc. (USOTC: PAOG) today announced a management update on the company’s ongoing CBD Pharmaceutical Development Program progress scheduled to be ...
SANDUSKY, Ohio, April 12, 2021 /PRNewswire/ — PAO Group, Inc. (USOTC: PAOG) today confirmed a management update on the company’s ongoing CBD Pharmaceutical Development Program progress scheduled to be ...
SANDUSKY, Ohio, April 8, 2021 /PRNewswire/ — PAO Group, Inc. (USOTC: PAOG) today announced a management update on the company’s ongoing CBD Pharmaceutical Development Program progress scheduled to be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results